metformin has been researched along with Epstein-Barr Virus Infections in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonglack, EN | 1 |
| Messinger, JE | 1 |
| Cable, JM | 1 |
| Ch'ng, J | 1 |
| Parnell, KM | 1 |
| Reinoso-Vizcaíno, NM | 1 |
| Barry, AP | 1 |
| Russell, VS | 1 |
| Dave, SS | 1 |
| Christofk, HR | 1 |
| Luftig, MA | 1 |
1 other study available for metformin and Epstein-Barr Virus Infections
| Article | Year |
|---|---|
Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas.
Topics: B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Epstein-Barr Virus Infections; Glucose; Glutath | 2021 |